Treatment of pemphigus
US9993550B2 · kind B2 · utility
0Cited by
78References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 16, 2015 |
| Grant date | Jun 12, 2018 |
| Priority date | — |
| Expiry date | Jul 16, 2035 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S424/81
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention concerns treatment of pemphigus with an antibody which binds to CD20.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.